SERPINF1 and familial pancreatic carcinoma: Though PEDF is a potent anti-angiogenic factor [53], pancreatic cancer-associated hypovasculatory and hypoxia are not likely mediated by PEDF, given that most patients have significantly reduced levels of PEDF.